Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank83
3Y CAGR+207.0%
5Y CAGR+69.2%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+207.0%/yr
Annual compound
5Y CAGR
+69.2%/yr
Recent acceleration
Percentile
P83
Within normal range
vs 5Y Ago
13.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $2.95M | -34.4% |
| 2023 | $4.50M | +332.2% |
| 2022 | $1.04M | +920.6% |
| 2021 | $102000.00 | +24.4% |
| 2020 | $82000.00 | -61.5% |
| 2019 | $212999.00 | -82.7% |
| 2018 | $1.23M | - |